NEW YORK (GenomeWeb News) – The National Institutes of Health has awarded an undisclosed research grant to Integrated Genomics, the University of Pittsburgh, and the University of Notre Dame to analyze pathogens and bioterrorism agents, Integrated Genomics said today.
The project will target three bacterial bioterrorism agents, including Bacillus anthracis, Yersinia pestis, and Francisella tularensis, and two drug-resistant bacteria, Pseudomonas aeruginosa and Staphylococcus aureus.
Integrated Genomics will use its ERGO bioinformatics platform to build metabolic reconstructions based on these organisms’ genomic sequences.
The research program aims to identify and validate small-molecule inhibitors against enzyme targets that could serve as leads to new antibiotics.
The University of Pittsburgh and Integrated Genomics expect the current project to run through 2011.
The University of Pittsburgh and Integrated Genomics expect the current project to run through 2011.